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ABSTRACT

PATIENT’S EXPERIENCE

This article is co-authored by a patient with
oesophageal adenocarcinoma and his physician, who performed oesophagectomy. The
patient relates his pre-operative preparation and
post-operative experience. The physician comments on the alarming increase in the incidence
of this cancer, risk factors, and treatment. As
illustrated by the patient’s report, the physician
also discusses the importance of maintaining
adequate nutrition, cardiorespiratory fitness,
and a positive psychological attitude.

I was born in the UK in 1940. Apart from a
broken arm when I was 9 years old, my most
serious illness was TB in the leg in 1954, for
which I was treated with streptomycin. After my
recovery, I enjoyed playing many sports. Later
in life, I took up golf.
I have never smoked. I have never been
considered seriously overweight. I enjoy drinking red wine, usually with my evening meal. On
retirement, my wife and I emigrated to Australia
in July 2006. In early 2008, I occasionally
experienced some difficulty swallowing the first
mouthful of a sandwich. This difficulty soon
passed as I continued eating. It was during a trip
to the UK in August 2008 that I suddenly
experienced a serious swallowing problem on
two separate occasions within 2 days of each
other. On our return to Australia, I immediately
contacted my GP who arranged for me to have
an endoscopy. I had experienced occasional
indigestion in the previous few years which was
not painful nor could it be considered to be
heartburn. Relief was obtained through proprietary indigestion tablets. My GP felt that my
swallowing problem could be caused by a hiatal
hernia which might have also explained my
periodic indigestion when eating rich or spicy
foods.
I was referred to a local specialist for the
endoscopy. The specialist felt he had seen a
cancerous tumour at the lower end of my
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oesophagus. He took biopsies and coloured
photographs of the tumour and arranged for me
to have a CT and PET scan. I was then referred
to Professor R. V. Lord at St Vincent’s Clinic,
Sydney.
Armed with my full body scan results and
photographs taken during the endoscopy, I
attended my first consultation with Professor
Lord who requested I should have an ultrasound scan and fine needle biopsy taken of the
tumour. The biopsy results showed that cancer
cells were present in the tumour and surrounding lymph nodes, and I was diagnosed
with a Stage II adenocarcinoma. I had no reflux
prior to my swallowing discomfort in August
2008. My diagnosis for Stage II oesophageal
cancer was made in its early stages and, therefore, the prognosis for successful surgery and
recovery was encouraging.
My pre-surgery treatment included a 9-week
course of chemotherapy carried out at the
Cancer Clinic in Bowral and involved a visit to
the clinic on each of the 9 weeks. I did not
experience the more extreme side-effects during
the chemotherapy treatment; the most obvious
being the loss of my head hair and the need for
toilet trips in the middle of the night. The nature of the intended surgery was explained to
me. I was advised that I might experience some
difficulty with breathing and trying to sit up
unaided as a result of the surgery. I decided to
tone-up the muscles around my chest and
abdomen during my chemotherapy course. My
son-in-law is a sports trainer, and he devised a
simple daily exercise program for me to follow,
which had the effect of improving my general
physique and gaining a few grams in weight
throughout the 9-week chemotherapy course. I
had a scientific background as a physicist, so
throughout the 9 weeks of treatment, I kept a
detailed daily diary recording my weight, blood
pressure, exercises, food intake, and general
activity including bowel movements to see if
there was anything that might be helpful to
discuss with my oncologist. The objective of the
chemotherapy was to reduce the size of the
tumour to make the surgery less invasive. I
recall asking my oncologist at the beginning of
the treatment whether an improvement in
swallowing food was indicative that the tumour
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size was reducing. Bearing in mind that difficulty in swallowing bread was the only symptom I had before the tests revealed I had
oesophageal cancer, I regarded my question as
essential for me to maintain the positive outlook I had adopted when my diagnosis was
confirmed. After about 4 weeks into the treatment, there was a sudden and noticeable
improvement in my ability to eat and swallow
food, especially bread. I felt encouraged that the
chemotherapy treatment was achieving the
objective. It was noted that my weight had
increased through the 9-week period. As a
result, I am convinced that my immediate
recovery period after the surgery was made
easier and shorter by being fairly fit before
entering hospital. My weight immediately prior
to surgery was 82 kg (180 lb), slightly higher
than the average weight for a person of my
height, which is 182 cm [body mass index
(BMI): 24 [healthy weight range 18.5–25].
Following my surgery, I undertook physical
exercises under the direction of the hospital
physiotherapist. Pain management was critical
in the days immediately after my surgery. I was
connected to an intravenous pump to administer
morphine on demand should I require it. I limited the use of the pump to those times when I
tried sitting up in bed un-aided. Walking around
the wards required a small team of assistants to
carry the various tubes and intravenous equipment still attached to me! I was unable to take
drink or food for the first 6 days of my recovery.
After 6 days, I was given an X-ray after consuming a drink containing a dye to see if my
re-engineered digestive system was leaking or
not. The results were satisfactory, and I was
allowed to drink water for the first time since the
surgery. After 6 days, I felt able to sit up in bed
without the need for painkillers and this facility
was removed. My food intake was restricted to
clear soup and jelly. I continued walking around
the wards and taking exercises until my discharge
from hospital. I was hospitalised for a total of
9 days. My weight at the time of being discharged
from hospital was 67 kg (147 lb; BMI: 20). I am
convinced that undertaking a program of physical exercises prior to my oesophageal cancer
surgery contributed to my relatively short hospitalised recovery period.
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After the surgery, I agreed to undertake
another 9-week course of chemotherapy recommended as ‘‘insurance’’ against any lingering
cancer cells remaining from the surgery. The
second course of treatment was exactly the
same as the first. Although I had a reasonable
experience during the pre-surgery chemotherapy course, I did feel much weaker during the
post-surgery chemotherapy and felt the need for
a mid-afternoon nap each day. Again, I seemed
to escape most of the possible side-effects of
chemotherapy except for the loss of my body
hair for the second time and the regular nightly
toilet trips! I continued to keep up my morning
exercises and kept a daily diary as before
throughout the 9-week course in case there was
anything significant to discuss with my oncologist. After the 9-week course, I encouraged
myself to believe that I was now on the way to a
speedy and complete recovery.
On reflection, I probably tried too hard too
soon to get back to the eating habits I had prior
to my swallowing problem of August 2008, and
as such, I found difficulties in understanding
how my re-engineered digestive system might
react to certain foods, including the quantities
contained in specific meals and my subsequent
bowel movements, which lacked consistency
through most days. I even graded my daily
bowel movements on a scale from 1 to 5 to
monitor any pattern that may have been
established. I was probably guilty of having
expectations that exceeded the reality of my
situation, and I soon realised and accepted that
I needed to develop more patience throughout
the period of my post-surgery recovery, which
was clearly taking much longer than I had
anticipated.
I enjoyed normal meals, including those
containing red or white meat and vegetables.
However, 5 months after my surgery and on
rare occasions, I developed hiccups after the
first mouthful and I experienced some discomfort and difficulty in swallowing and could not
continue my meal until I cleared what appeared
to be trapped wind in my stomach. The phenomenon was unpredictable. I took this as a
wake-up call either to chew each mouthful of
food for longer or to slow down the rate at
which I tried eating my food. The symptoms of
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the swallowing problem were similar to when I
had the blockage the previous year due to
oesophageal cancer but the fact that I was able
to resume normal eating after clearing the
stomach wind suggested that my discomfort
was a form of reflux rather than any physical
problem with my re-engineered digestive system. To ease the situation further, my GP prescribed a proton pump inhibitor (omeprazole),
which I continue to take daily, and this seemed
to gradually improve my ability to eat well
consistently without the fear of reflux. My
bowel movements varied from passing normal
stools early each morning to much looser
movements some 3 h later after which I felt
quite exhausted and debilitated. This discomfort continued for 3 years after my surgery and
is sometimes called ‘‘late dumping syndrome’’,
which I understand is not uncommon for
patients who have undergone intestinal
surgery.
Another painful episode was due to the
phenomenon unknown to me at the time called
adhesions. My first experience occurred
8 months after my surgery whilst driving. I
suddenly had excruciating pains in my lower
abdomen, which remained with me for 24 h.
During this time, I felt constipated and vomited
several times before the pain subsided. I avoided
eating any solid food for 24 h and visited my
GP, who arranged for X-rays to determine
whether there was any blockage in my system.
Fortunately, the results were satisfactory, and
my GP explained adhesions and how they
formed after internal surgery and sometimes
break away causing minor blockages and subsequent pain. Twelve months after the first
painful experience, I suffered another similar
painful effect of adhesions for 24 h and was able
to recognise the symptoms. Although I was in
some discomfort for that period, I did not have
the fear-factor and the discomfort soon passed.
Over the following 2 years or so, I experienced
lesser periods of discomfort, similar to the first
two attacks, but with less pain and for a shorter
time until eventually, the discomfort stopped.
I do sometimes experience some physical
discomfort from adhesions, which have made
the internal area around my liver and stomach
‘‘sticky’’, and I feel the occasional need to
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stretch to maintain the flexibility around the
surgery scars, mainly at the bottom of my right
rib cage and lung. I attend a weekly yoga class,
which lessens the tightening effect I sometimes
experience from the scars around the side of my
body where the main surgical incisions were
made. I occasionally experience an effect where
my voice appears to break whilst speaking due
to mild acid reflux causing the occasional
inflammation of the throat. I also have some
numbness in my big toes, which is caused by
nerve damage from the platinum in one of the
chemotherapy agents. However, these are mild
discomforts that I recognise and I am able to
manage, causing no limitations or restrictions
on my life style.
It is over 8 years since the symptoms of my
oesophageal cancer first appeared in 2008. I
have an annual gastroscopy to inspect and take
biopsies from my oesophagus. I continue to
take omeprazole daily to prevent reflux, and I
use three pillows in bed to ensure that my head
remains higher than the rest of my body to
minimise the possibility of acid reflux during
the night. I eat regular meals and take a
mid-morning and mid-afternoon snack with my
coffee or tea. I consider myself to be as fit as I
possibly could be after my surgery which I
attribute to the excellent medical treatment I
have received and to my positive outlook for
the future. If there are two lessons I have
learned from my experience with oesophageal
cancer, they are the need for pre-surgery
preparation and post-surgery patience.

PHYSICIAN’S PERSPECTIVE
Mr. Maule’s description of his experience with
oesophageal cancer is written in a remarkably
clear, straightforward fashion. He had an esophageal adenocarcinoma (EAC), which was a
rare cancer throughout most of recorded medical history, but has become increasingly more
common during the latter half of the twentieth
century. Indeed, for reasons that remain
unknown, the incidence of EAC has increased at
a rate greater than any other cancer in recent
decades, with a more than sixfold increase in
the United States.
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Mr. Maule’s story includes some valuable
information for those with EAC and also for
those working to improve the outlook for
patients. Consistent with the presumed multistage carcinogenesis model for EAC, his tumor
developed in a segment of Barrett’s esophagus.
Chronic severe gastroesophageal reflux disease
is the major etiological factor for Barrett’s disease, but Mr. Maule denies having had any
typical reflux symptoms. He experienced ‘‘indigestion’’ shortly before the EAC diagnosis, but
does not give a history of heartburn or regurgitation. In the absence of upper gastrointestinal
symptoms he had not undergone endoscopy
prior to the cancer diagnostic endoscopy and
consequently, like most individuals with Barrett’s esophagus, he was unaware that he had
Barrett’s disease.
This illustrates a major problem for improving the current dismal survival statistics for
EAC: although the cancer is usually curable
when diagnosed early in patients with known
Barrett’s esophagus who undergo surveillance
endoscopy, most patients with Barrett’s are
undiagnosed as they have not had endoscopy.
Since the cost of endoscopy precludes population screening, novel non-endoscopic diagnostic strategies are needed. In this regard, many
research teams are seeking a less invasive, less
expensive diagnostic test, such as a blood test
for Barrett’s esophagus, EAC, or both.
Besides the major risk factor of Barrett’s
esophagus, Mr. Maule is also male, age over
60 years, and has Caucasian ancestry as risk
factors for EAC. EAC has one of the strongest
associations with obesity, but he had never been
seriously overweight and he had never used
tobacco, another risk factor. He enjoys drinking
red wine, which, like alcohol use in general,
does not increase risk of EAC.
Mr. Maule presented with dysphagia, in his
case with a sandwich. Bread, meat, and rice are
common precipitants of solid food dysphagia.
When patients present with dysphagia this is
usually a sign that more than 60% of the esophageal circumference is involved by cancer
and the luminal diameter is less than 12 mm.
One interesting aspect of Mr. Maule’s
account is that soon after receiving his cancer
diagnosis he began to improve his physical
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condition in preparation for esophagectomy.
This is recommended for all patients, but few
adopt this suggestion with the same diligence.
His son-in-law, a professional sports trainer,
devised an exercise program to improve fitness
in general and core thoraco-abdominal and
respiratory fitness in particular. As Mr. Maule
writes, his immediate postoperative recovery
seems likely to have been easier and shorter
through being fit prior to surgery. It has been
difficult to prove that such measures provide a
significant benefit: a non-randomized study of
patients undergoing esophagectomy found that
inspiratory muscle training, which includes
deep breathing exercises, incentive spirometry,
and other activities, improved respiratory
function, but not surgical outcomes [1]. Similar
results are found for other operations, but study
quality is mostly low for these reports. As recommended by a Cochrane review, there is an
urgent need for high quality, adequately powered, randomized trials [2].
Displaying the traits of his past career in
physics, Mr. Maule also kept a diary recording
daily food intake, weight, and other factors.
Unusually, he was able to gain weight during
the pre-operative chemotherapy treatment period. The importance of nutrition in patients
with esophageal cancer and malnutrition due to
dysphagia, weight loss, and cachexia, is widely
accepted [3, 4]. For patients without obvious
malnutrition, like Mr. Maule, there are no
compelling data regarding nutritional supplementation, but it is recommended that
enhanced enteral nutrition should be provided
during chemo- and radiotherapy treatment [5].
Immune-enteral nutrition may be especially
beneficial; pre-operative provision of specialized
nutritional support with immune-modulating
nutrients reportedly results in less post-operative morbidity and is cost-effective for major
operations, including esophagectomy [6].
Mr. Maule refers to the positive attitude he
adopted at the time of diagnosis and how he
was able to maintain this attitude throughout
the arduous treatment, for example by focussing on his improved swallowing during
chemotherapy treatment. Attributes such as
hope and optimism regarding the future, part of
the wider field known as positive psychology,

83

have become areas of increased research interest
in the past two decades. Adopting a ‘‘positive
attitude’’ is believed by many to help with
managing the emotional, psychological, social,
economic, and relationship difficulties that
arise with a cancer diagnosis. An optimistic
outlook may be associated with more active
coping strategies [7, 8]. Reports on esophageal
cancer patients are awaited, but optimism level
predicted survival at 1 year after head and neck
cancer diagnosis in one study [9], and in
another study patients who were assessed as
being more optimistic generally coped better
with a diagnosis of early breast cancer than
those who were more pessimistic [10].
Regarding his operative treatment, Mr.
Maule underwent esophagectomy with en bloc
lymphadenectomy. This extensive operation is
not performed by most surgeons. None of the
43 lymph nodes removed in his case showed
involvement by cancer on histopathological
examination of the resection specimen. Mr.
Maule can be considered cured as he has survived well beyond 5 years after treatment, and
in retrospect a less extensive operation would
probably also have cured this cancer—but
lymph node involvement is difficult to assess
with certainty pre-operatively. Reports from
other surgeons who perform an en bloc
esophagectomy indicate that this operation
provides the highest likelihood of surgical cure
[11], especially for those with metastasis to a
limited number of lymph nodes (estimated at
up to 8 nodes) [12, 13]. This article does not
contain any new studies with human or animal
subjects performed by any of the authors.
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